MEP3708A - Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use - Google Patents

Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use

Info

Publication number
MEP3708A
MEP3708A MEP-37/08A MEP3708A MEP3708A ME P3708 A MEP3708 A ME P3708A ME P3708 A MEP3708 A ME P3708A ME P3708 A MEP3708 A ME P3708A
Authority
ME
Montenegro
Prior art keywords
wort
john
pharmaceutical compositions
proteins
hypericum perforatum
Prior art date
Application number
MEP-37/08A
Other languages
English (en)
Croatian (hr)
Inventor
Christoph Schempp
Andrea Jocher
Kathrin Engel
Constance Huyke
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of MEP3708A publication Critical patent/MEP3708A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Predmet pronalaska je postupak za prečišćavanje farmakološki aktivnih proteina, zasnovanih na upotrebi katjonske izmjenjivačke hromatografije na čvrstom nosaču izvođenom na baznijim pH, tj. višim, u odnosu na pH koji odgovara izoelektričnoj tačci, pI, proteina koji se prečišćavaju, pH na kojem su međutim pomenuti proteini još uvijek zaostali absorbovani. Rastvori pufera sa vrijednošću pH i jonskom jačinom podešenom sa vremena na vrijeme vrsti farmakološki aktivnih proteina koji se prečišćavaju se koristi u cilju dobijanja takvih rezultata. Postupak se uglavnom odnosi na prečišćavanje interferona i albumin proteina.
MEP-37/08A 2004-04-19 2005-04-07 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use MEP3708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04009213A EP1591125A1 (de) 2004-04-19 2004-04-19 Pharmazeutische Zusammensetzung enthaltend Extrakte aus Flechten und Johanniskraut
PCT/EP2005/003657 WO2005099728A1 (de) 2004-04-19 2005-04-07 Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung

Publications (1)

Publication Number Publication Date
MEP3708A true MEP3708A (en) 2010-06-10

Family

ID=34924650

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-37/08A MEP3708A (en) 2004-04-19 2005-04-07 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use

Country Status (13)

Country Link
US (1) US7687083B2 (bs)
EP (2) EP1591125A1 (bs)
AT (1) ATE376427T1 (bs)
CA (1) CA2563870C (bs)
DE (1) DE502005001791D1 (bs)
ES (1) ES2294697T3 (bs)
HR (1) HRP20070579T3 (bs)
ME (1) MEP3708A (bs)
PL (1) PL1755630T3 (bs)
RS (1) RS50550B (bs)
RU (1) RU2358750C2 (bs)
SI (1) SI1755630T1 (bs)
WO (1) WO2005099728A1 (bs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2448577T3 (pl) * 2009-06-30 2017-02-28 Derman Biomedicine Co. Ltd. Kompozycje zawierające berberynę lub jej analogi do leczenia trądziku różowatego lub chorób skóry związanych z zaczerwienieniem twarzy
GB0919210D0 (en) * 2009-11-03 2009-12-16 Syntopix Ltd Formulations
GB201021745D0 (en) * 2010-12-22 2011-02-02 Syntopix Group Plc Formulations
CN102949298A (zh) * 2011-12-20 2013-03-06 上海莱博生物科技有限公司 松萝酸和/或其盐的应用
RS54162B1 (sr) * 2011-12-28 2015-12-31 Univerzitet U Beogradu Farmaceutska kompozicija na bazi lekovitog bilja za primenu u humanoj i veterinarskoj medicini
RU2582978C2 (ru) * 2014-01-14 2016-04-27 Федеральное государственное бюджетное учреждение науки Институт экологических проблем Севера Уральского отделения Российской академии наук СПОСОБ ПОЛУЧЕНИЯ ТВЕРДОГО ЭКСТРАКТА, ОБОГАЩЕННОГО УСНИНОВОЙ КИСЛОТОЙ, ИЗ СЛОЕВИЩ ЛИШАЙНИКА РОДА "Cladonia"
CN105076246A (zh) * 2015-08-28 2015-11-25 无限极(中国)有限公司 一种抗菌中药组合物及其制备方法、应用
WO2018112666A1 (en) * 2016-12-23 2018-06-28 Klox Technologies Inc. Biophotonic compositions comprising lichen extract and their use to treat skin disorders
CN106943341B (zh) * 2017-05-10 2020-01-24 重庆理工大学 一种改善松萝酸透皮吸收的外用制剂及其在促皮肤创伤愈合中的应用
AU2018304125B2 (en) * 2017-07-19 2020-08-27 Colgate-Palmolive Company Personal care compositions comprising zinc:usnic acid complexes and methods of use
CN108938509B (zh) * 2018-10-16 2021-06-18 头皮医生健康管理(中国)有限公司 去屑止痒组合物及其制备方法和其应用
WO2021191800A1 (en) * 2020-03-23 2021-09-30 Kerecis Ag Antimicrobial solutions and methods of using the same in the treatment or prevention of infections
IT202000008536A1 (it) 2020-04-21 2021-10-21 Pellegrino Masiello Composizione e metodo per il trattamento delle fasi intermedie della covid-19 e simili patologie virali con risposta infiammatoria sistemica
CN113876645B (zh) * 2020-07-01 2024-01-05 伽蓝(集团)股份有限公司 一种须松萝提取物及其应用和含其的皮肤外用剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05246876A (ja) * 1992-03-07 1993-09-24 Nippon Paint Co Ltd 抗菌剤
JPH0818956B2 (ja) * 1993-06-14 1996-02-28 花王株式会社 養毛・育毛料
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions

Also Published As

Publication number Publication date
US7687083B2 (en) 2010-03-30
EP1755630B1 (de) 2007-10-24
WO2005099728A1 (de) 2005-10-27
RU2358750C2 (ru) 2009-06-20
PL1755630T3 (pl) 2008-03-31
DE502005001791D1 (de) 2007-12-06
ES2294697T3 (es) 2008-04-01
ATE376427T1 (de) 2007-11-15
RU2006140864A (ru) 2008-05-27
HRP20070579T3 (en) 2008-01-31
US20080233145A1 (en) 2008-09-25
RS50550B (sr) 2010-05-07
EP1591125A1 (de) 2005-11-02
EP1755630A1 (de) 2007-02-28
SI1755630T1 (sl) 2008-02-29
CA2563870C (en) 2013-02-19
CA2563870A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
MEP3408A (bs) Postupak za prečišćavanje farmakološki aktivnih proteina pomoću katjonske izmjenjivačke hromatografije
DK1075488T4 (da) Proteinoprensning ved ionbytningskromatografi
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
CY1116110T1 (el) ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
RU2012130151A (ru) Промывочный раствор и способ промывки для аффинной хроматографии
EP0921818A4 (en) THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS BASED ON JAGGED / NOTCH PROTEINS AND AMINO ACIDS
DE69132671D1 (de) Protein-g-gekoppelte glutaminsäure-rezeptoren
SE0201518D0 (sv) Albumin Purification
CY1108460T1 (el) Μεθοδος για τον καθαρισμο ανασυνδυασμενης hcg (ανθρωπινης χοριονικης γοναδοτροπινης) που εχει ειδικη βιοδραστικοτητα
JP2010524472A5 (bs)
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
AR051512A1 (es) Proteina de fusion que comprende un dominio bh3 de una proteina "solo bh3"
BRPI0407533A (pt) proteìnas de fusão e muteìnas do interferon alfa com propriedades melhoradas
HRP20050371B1 (hr) Oblik za primjenu farmaceutiski djelatnih peptida s produljenim oslobađanjem djelatnog sastojka i postupak za njihovu proizvodnju
UA35639C2 (uk) Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
EP1664322A4 (en) RECOMBINANT CARRIER MOLECULE FOR THE EXPRESSION, INTAKE AND CLEANING OF TARGET POLYPEPTIDES
ES2070855T3 (es) Metodo para purificar una proteina.
ATE417056T1 (de) Verfahren zur proteinreinigung
CY1110296T1 (el) Χρηση αμινων ή αμινοξεων ως τροποποιητες κινητης φασης στη χρωματογραφια
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
ATE520025T1 (de) Test für morbus-parkinson-therapeutika
CY1107514T1 (el) Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια
ATE496133T1 (de) Affinitätspolypeptid zur reinigung von rekombinanten proteinen
DE69839733D1 (de) Mit syndekan interagierende proteine und deren verwendung